Enterococcus faecalis and pathogenic streptococci inactivate daptomycin by releasing phospholipids
Open Access
- 1 October 2017
- journal article
- research article
- Published by Microbiology Society in Microbiology
- Vol. 163 (10) , 1502-1508
Abstract
Daptomycin is a lipopeptide antibiotic with activity against Gram-positive bacteria. We showed previously that Staphylococcus aureus can survive daptomycin exposure by releasing membrane phospholipids that inactivate the antibiotic. To determine whether other pathogens possess this defence mechanism, phospholipid release and daptomycin activity were measured after incubation of Staphylococcus epidermidis, group A or B streptococci, Streptococcus gordonii or Enterococcus faecalis with the antibiotic. All bacteria released phospholipids in response to daptomycin, which resulted in at least partial inactivation of the antibiotic. However, E. faecalis showed the highest levels of lipid release and daptomycin inactivation. As shown previously for S. aureus, phospholipid release by E. faecalis was inhibited by the lipid biosynthesis inhibitor platensimycin. In conclusion, several pathogenic Gram-positive bacteria, including E. faecalis, inactivate daptomycin by releasing phospholipids, which may contribute to the failure of daptomycin to resolve infections caused by these pathogens.Keywords
All Related Versions
This publication has 36 references indexed in Scilit:
- Daptomycin-Mediated Reorganization of Membrane Architecture Causes Mislocalization of Essential Cell Division ProteinsJournal of Bacteriology, 2012
- Oligomerization of daptomycin on membranesBiochimica et Biophysica Acta (BBA) - Biomembranes, 2011
- Contribution of bacterial outer membrane vesicles to innate bacterial defenseBMC Microbiology, 2011
- Daptomycin Exerts Bactericidal Activity without Lysis of Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2008
- Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: Comparison with cationic antimicrobial peptides and lipopeptidesBiochimica et Biophysica Acta (BBA) - Biomembranes, 2006
- Platensimycin is a selective FabF inhibitor with potent antibiotic propertiesNature, 2006
- Correlation of Daptomycin Bactericidal Activity and Membrane Depolarization in Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2003
- σBModulates Virulence Determinant Expression and Stress Resistance: Characterization of a FunctionalrsbUStrain Derived fromStaphylococcus aureus8325-4Journal of Bacteriology, 2002
- Scanning Electronmicroscopy of Staphylococcus Aureus and Enterococcus Faecalis Exposed to DaptomycinJournal of Medical Microbiology, 1989
- Comparative Susceptibility of Group B Streptococci and Staphylococcus aureus to Killing by Oxygen MetabolitesThe Journal of Infectious Diseases, 1985